Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
accelerated approval
Biotech
Ultragenyx gets green light to seek FDA approval of gene therapy
With the FDA agreeing a biomarker is a reasonable surrogate endpoint, Ultragenyx is preparing to file for approval of its Sanfilippo gene therapy.
Nick Paul Taylor
Jun 13, 2024 5:55am
How Peter Marks plans to prevent '3 billion visits' to FDA
May 8, 2024 11:05am
FDA's Richard Pazdur explains confirmatory trial rejection, more
Apr 8, 2024 6:00am
Sarepta's next DMD drug seems to get the job done in phase 2
Jan 29, 2024 10:49am
Amgen's tarlatamab BiTEs at SCLC in brief readout
Aug 3, 2023 4:01pm
FDA's Marks wants more quick approvals for rare disease drugs
Jul 28, 2023 11:36am
